로고

  • HOME
  • SITEMAP
  • kOREAN
Home > SmartFilm®Technology > Overview

SmartFilm® Technology is a breakthrough innovative technology to produce Orally Disintegrating Film(ODF) dosage forms, which is rapidly progressing development and commercialized in the pharmaceutical area, and is SPC’s ambitious project targeting to the global market.

Regardless of many advantages of ODF, still there are few companies in worldwide establishing R&D capability and production technology because of the technological limitations such as loading dose, taste masking, complicated manufacturing process and process engineering. However, SmartFilm® Technology, which is a cutting-edge technology that overcomes the limitations of production technology in conventional ODF, such as loading dose, taste masking and etc, and serves as a stepping-stone for clear-cut comparative advantage of cGMP-level production facility, can lead a high valued technology in pharmaceutical areas.

SPC has produced SmartFilm with the establishment of cGMP grade facilities including ODF manufacturing facilities in Osong Bio-health Science Technopolis. It already got PIC/S GMP approval. Osong plant is constructing at a cGMP level to prepare for SmartFilm® pipeline and is planning to install an additional full line of production through the technological collaboration with outsourcing groups. All manufacturing process is strictly planning to be controlled according to the cGMP guidelines in order to make inroads for US and EU market.

SmartFilm® Technology can be used to an evergreen strategy to prevent from market penetration of generics, so that the compositions and merits of dosage forms are protected through patent registration by converting patent-expired products into SmartFilm® ODF forms. Meanwhile, SmartFilm® Technology is an infrastructural technology on the production of ODF dosage forms and makes it possible for CMO partnership on existing therapeutic group requiring high dose API based on the generality of cutting-edged manufacturing technology.